AstraZeneca announced that it is spending up to $1bn to acquire Belgian biotech firm EsoBiotec, which it says has the potential to "transform" cell therapy. EsoBiotec’s in vivo delivery platform, ...

FDA finds benzene contamination, Tronox to close a pigment plant, Sofinnova launches a European biotech fund, and more ...

European stocks are expected to start the new trading week in positive territory, though investors will be looking to see if ...

It has already been speculated that AstraZeneca's termination of a plan to invest £450 million in a new vaccine manufacturing ...

The ceremony will take place on May 28, celebrating the trailblazers transforming the legal industry through technology and ...

The government has identified life sciences as one of the sectors with the highest potential for growth in the UK and plans to make it a key pillar of its upcoming industry strategy. The ...

Called Biovelocita II, the fund was backed by major pharmaceutical companies Amgen and Bristol Myers Squibb as well as Pfizer ...

Correspondence seen by The Irish Times shows several big pharma companies, such as Pfizer, MSD, Novo Nordisk and AstraZeneca, ...

The European stock markets were moving higher in Monday trading as The Stoxx Europe 600 rose 0.75%, Germany's DAX was up 0.61%, the FTSE 100 in London gained 0.58%, France's CAC 40 increased 0.50%, ...

Pharmaceutical companies are currently granted at least eight years’ “protection” over their data from research and clinical ...